Recent Publications on Neuroendocrine Tumors: |  |
Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma.
Pheochromocytoma and paraganglioma (PGL) are rare neuroendocrine tumors in...
Direct Link | 21st November, 2009
| Department of Pediatrics, University of Mississippi Medical Center,
|
| Expression of Reg IV and Hath1 in neuroendocrine neoplasms.
| 20th November, 2009
| Department of Pathology, Haartman Institute, University of Helsinki,
|
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines.
Background: Therapeutic approaches to gastroenteropancreatic...
Direct Link | 20th November, 2009
| Gastroenterologie/Infektiologie/Rheumatologie, Medizinische Klinik I,
|
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway.
PURPOSE: We investigated the global gene expression in a large panel of...
Direct Link | 18th November, 2009
| Departments of Pathology and Surgical and Gastroenterological Sciences,
|
Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program.
Primary neuroendocrine tumors of the gallbladder (GB) and extrahepatic...
Direct Link | 18th November, 2009
| Instituto Nacional de Ciencias Medicas y Nutricion, CP 14000 Mexico City,
|
Limited Value of 18F-F-DOPA PET to Localize Pancreatic Insulin-Secreting Tumors in Adults with Hyperinsulinemic Hypoglycemia.
Context: Fluorine-18-L-dihydroxyphenylalanine positron emission tomography...
Direct Link | 17th November, 2009
| Service Central de Biophysique et de Medecine Nucleaire (L.T., D.T.,
|
Isocitrate Dehydrogenase Mutations Are Rare in Pheochromocytomas and Paragangliomas.
Context: Paragangliomas and pheochromocytomas are neuroendocrine tumors...
Direct Link | 17th November, 2009
| Department of Pathology (J.G., E.K., R.R.d.K., W.N.M.D.), Josephine
|
Sunitinib paves the way for targeted therapies in neuroendocrine tumors.
Sunitinib demonstrating efficacy in pancreatic islet cell carcinomas will...
Direct Link | 17th November, 2009
| Department of Medical Oncology and Gastroenterology, Beaujon University
|
18F-FDOPA: A Multiple-Target Molecule.
Although 6-(18)F-fluoro-L-dopa ((18)F-FDOPA) has been available to study...
Direct Link | 17th November, 2009
| Department of Oncology and Radiotherapy, Turku University Hospital, Turku,
|
A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors.
Our purpose was to compare the performance of...
Direct Link | 17th November, 2009
| Institute of Nuclear Medicine, University College Hospital, UCLH, London,
|
Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center.
Neuroendocrine tumors originate from neuroendocrine cells and occur in a...
Direct Link | 13th November, 2009
| Department of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul
|
Molecular targeted therapies in the treatment of gastroenteropancreatic neuroendocrine tumors.
Gastroenteropancreatic neuroendocrine tumors (GEPNETs) are rare neoplasms...
Direct Link | 10th November, 2009
| Department of Medical Oncology, Vall d'Hebron University Hospital,
|
| The utility of 99mTc-EDDA/HYNIC-TOC scintigraphy for assessment of lung lesions in patients with neuroendocrine tumors.
| 10th November, 2009
|
|
Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies.
Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits...
Direct Link | 10th November, 2009
| Oncology Unit, Third Department of Medicine, Athens University School of
|
